Table 5.
Category | Clouster | Treatment | Linkage group | Peak position (cM) | Confience interval (cM) | ADDa | QTL numbers included | sQTLs included |
---|---|---|---|---|---|---|---|---|
RM-specific QTL cluster | qcA01-1 | LN | A01 | 44.92 | 43.05–46.8 | − | 2 | sqTRN.A01 |
qcA01-2 | HN | A01 | 49.34 | 48.27–50.41 | − | 4 | sqTRN.A01 | |
qcA02-3 | LN | A02 | 67.41 | 65.19–69.64 | + | 2 | – | |
qcA05-1 | LN | A05 | 28.13 | 27.98–28.27 | − | 2 | – | |
qcA07-1 | HN | A07 | 62.8 | 62.46–63.15 | + | 4 | sqTRL.A07-2 | |
qcA07-2 | HN/LN | A07 | 65.2 | 64.83–65.58 | + | 3 | – | |
qcA07-3 | HN/LN | A07 | 67.2 | 66.23–68.18 | + | 5 | sqTRN.A07-1 | |
qcA07-4 | HN | A07 | 71.4 | 70.46–72.34 | + | 3 | sqTRL.A07-3/sqTSA.A07/sqTRV.A07-1/sqTRN.A07-2 | |
qcA07-5 | HN/LN | A07 | 73.91 | 73.6–74.22 | + | 13 | sqTRL.A07-3/sqTSA.A07/sqTRV.A07-1/sqTRN.A07-2/sqRDW.A07-1 | |
qcA09-2 | LN | A09 | 101.94 | 99.07–104.81 | + | 5 | sqTSA.A09/sqRDW.A09 | |
NUE-specific QTL cluster | qcA01-3 | LN | A01 | 88.96 | 88.02–89.91 | − | 3 | sqSDW.A01 |
qcA01-4 | LN | A01 | 112.01 | 110.16–113.85 | ± | 2 | – | |
qcA02-2 | LN | A02 | 51.31 | 50.12–52.49 | ± | 2 | – | |
qcA04 | HN/LN | A04 | 79.84 | 79.15–80.52 | + | 6 | sqSDW.A04/sqSNU.A04 | |
qcA05-2 | LN | A05 | 36.15 | 35.5–36.81 | ± | 2 | – | |
qcA06 | LN | A06 | 149.18 | 146.88–151.48 | + | 2 | – | |
RM-NUE QTL cluster | qcA02-1 | HN/LN | A02 | 41.71 | 41.15–42.27 | + | 3 | sqRSRD.A02 |
qcA07-6 | HN/LN | A07 | 90.65 | 90.12–91.18 | − | 5 | sqTRV.A07-2 | |
qcA07-7 | LN | A07 | 99.05 | 98.02–100.09 | − | 4 | – | |
qcA07-8 | HN/LN | A07 | 106.31 | 104.77–107.84 | – | 5 | sqRDW.A07-2 | |
qcA09-1 | HN/LN | A09 | 33.71 | 28.96–38.45 | + | 4 | sqPRL.A09-3 | |
qcC04 | HN/LN | C04 | 69.66 | 69.37–69.94 | ± | 2 | – |
Positive and negative values represented corresponding QTLs carried the favorable alleles from ZS11 and No. 73290, respectively.